The direct mention of Dynavax's worse-than-expected Q1 financial results is a clear indicator of negative sentiment towards the stock. Financial performance, especially when it falls short of market expectations, is a critical driver of stock price movements in the short term. Given the specific mention of the company's underperformance, it's reasonable to expect a negative impact on the stock price as investors react to the news.